GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jyong Biotech Ltd (NAS:MENS) » Definitions » Total Long-Term Liabilities

MENS (Jyong Biotech) Total Long-Term Liabilities : $30.76 Mil (As of Dec. 2024)


View and export this data going back to 2025. Start your Free Trial

What is Jyong Biotech Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Jyong Biotech's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was $30.76 Mil.

Jyong Biotech Total Long-Term Liabilities Historical Data

The historical data trend for Jyong Biotech's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jyong Biotech Total Long-Term Liabilities Chart

Jyong Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
26.46 25.47 28.06 30.76

Jyong Biotech Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Liabilities Get a 7-Day Free Trial 25.47 - 28.06 29.43 30.76

Jyong Biotech Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Jyong Biotech Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Jyong Biotech's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jyong Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jyong Biotech Ltd (NAS:MENS) » Definitions » Total Long-Term Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi, New Taipei, TWN, 221
Website
https://www.healtheverbiotech.com
Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates.